Sodium-glucose cotransporter-2 inhibitor for renal function preservation in patients with type 2 diabetes mellitus: A Korean Diabetes Association and Korean Society of Nephrology consensus statement

Diabetes is a leading cause of end-stage renal disease. Therefore, prevention of renal dysfunction is an important treatment goal in the management of diabetes. The data of landmark cardiovascular outcome trials of sodiumglucose cotransporter-2 (SGLT2) inhibitors showed profound reno-protective effe...

詳細記述

保存先:
書誌詳細
主要な著者: Tae Jung Oh, Ju-Young Moon, Kyu Yeon Hur, Seung Hyun Ko, Hyun Jung Kim, Taehee Kim, Dong Won Lee, Min Kyong Moon, The Committee of Clinical Practice Guideline, Korean Diabetes Association and Committee of the Cooperative Studies, Korean Society of Nephrology
フォーマット: Artigo
言語:Inglês
出版事項: The Korean Society of Nephrology 2020-09-01
シリーズ:Kidney Research and Clinical Practice
主題:
diabetes mellitus
type 2
glomerular filtration rate
renal function
sodium-glucose transporter-2 inhibitors
オンライン･アクセス:https://doi.org/10.23876/j.krcp.20.132
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料